B of A Securities Maintains Buy on Hims & Hers Health, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Michael Cherny maintains a Buy rating on Hims & Hers Health (NYSE:HIMS) and raises the price target from $17.25 to $22.
June 03, 2024 | 11:58 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B of A Securities analyst Michael Cherny maintains a Buy rating on Hims & Hers Health and raises the price target from $17.25 to $22.
The Buy rating and increased price target from a reputable analyst at B of A Securities is likely to boost investor confidence and positively impact the stock price of Hims & Hers Health in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100